Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
Yuchen Liu, Xiaohui Wang, Yingzi Yang
Clin Mol Hepatol. 2020;26(4):742-750.   Published online 2020 Sep 28     DOI: https://doi.org/10.3350/cmh.2020.0178
Citations to this article as recorded by Crossref logo
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(2): 288.     CrossRef
TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome
Maryam Naghib, Ashraf Kariminik, Mohammad Kazemi Arababadi
Viral Immunology.2022; 35(1): 15.     CrossRef
CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity
Yan Fu, Hongfei Ci, Wei Du, Qiongzhu Dong, Huliang Jia
Pharmaceutics.2022; 14(2): 275.     CrossRef
Construction and Comprehensive Analysis of a circRNA-miRNA-mRNA Regulatory Network to Reveal the Pathogenesis of Hepatocellular Carcinoma
Meile Mo, Bihu Liu, Yihuan Luo, Jennifer Hui Juan Tan, Xi Zeng, Xiaoyun Zeng, Dongping Huang, Changhua Li, Shun Liu, Xiaoqiang Qiu
Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2022; 14(3): 711.     CrossRef
Parafibromin Is Highly Expressed in Hepatocellular Carcinoma and Its Expression Correlates with Poor Prognosis
Min-Kyung Kim
Journal of Clinical Medicine.2022; 11(7): 1773.     CrossRef
CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
Zibo Chen, Tao Yuan, Fangjie Yan, Song Ye, Qin Xie, Bo Zhang, Nengmin Lin, Qiaojun He, Bo Yang, Hong Zhu
BMC Cancer.2022;[Epub]     CrossRef
Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors
Hyunjung Park, Hyerin Park, Jiyeon Baek, Hyuk Moon, Simon Weonsang Ro
Biology.2022; 11(4): 585.     CrossRef
Hippo in Gastric Cancer: From Signalling to Therapy
Lornella Seeneevassen, Pierre Dubus, Caroline Gronnier, Christine Varon
Cancers.2022; 14(9): 2282.     CrossRef
Intrahepatic inflammatory IgA+PD-L1high monocytes in hepatocellular carcinoma development and immunotherapy
Pil Soo Sung, Dong Jun Park, Pu Reun Roh, Kyoung Do Mun, Sung Woo Cho, Gil Won Lee, Eun Sun Jung, Sung Hak Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Jonghwan Choi, Jaegyoon Ahn, Seung Kew Yoon
Journal for ImmunoTherapy of Cancer.2022; 10(5): e003618.     CrossRef
MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight
Luis M. Ruiz-Manriquez, Oscar Carrasco-Morales, E. Adrian Sanchez Z, Sofía Madeline Osorio-Perez, Carolina Estrada-Meza, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul
Frontiers in Genetics.2022;[Epub]     CrossRef
Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
Geofrey Mahiki Mranda, Zhi-Ping Xiang, Jun-Jian Liu, Tian Wei, Yinlu Ding
Frontiers in Oncology.2022;[Epub]     CrossRef
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
Journal of Viral Hepatitis.2021; 28(11): 1570.     CrossRef
Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
Kyung Joo Cho, Sun Yeong Shin, Hyuk Moon, Beom Kyung Kim, Simon Weonsang Ro
Translational Oncology.2021; 14(9): 101158.     CrossRef
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy
Ishfaq Hassan Mir, Shreyoshi Guha, Jajnasenee Behera, Chinnasamy Thirunavukkarasu
Cell Biology International.2021; 45(11): 2161.     CrossRef
Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches
Zahra Farzaneh, Massoud Vosough, Tarun Agarwal, Maryam Farzaneh
Cancer Cell International.2021;[Epub]     CrossRef
FAT1 and PTPN14 Regulate the Malignant Progression and Chemotherapy Resistance of Esophageal Cancer through the Hippo Signaling Pathway
Yingzhi Lu, Zhenxin Wang, Ling Zhou, Zhaoming Ma, Jianguo Zhang, Yan Wu, Yan Shao, Yunyun Yang, Lubna H. Tahtamouni
Analytical Cellular Pathology.2021; 2021: 1.     CrossRef
External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
The Hippo Pathway: A Master Regulatory Network Important in Cancer
Qiuping Liu, Xiaomeng Liu, Guanbin Song
Cells.2021; 10(6): 1416.     CrossRef
MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer
Na-Hyun Lee, So Jung Kim, Jeongeun Hyun
Biomedicines.2021; 9(4): 347.     CrossRef
Yes‑associated protein expression is associated with poor prognosis in patients with colorectal cancer
Liyu Cao, Cong Zhang, Qingqing Wu, Zhenzhen Bai, Jing Chen
Oncology Letters.2021;[Epub]     CrossRef